- Titer quantification of adenoviral vector stocks for gene therapy and vaccine development - Viral seed lot characterization and release testing - In-process monitoring during upstream production and downstream purification - Preclinical and clinical-grade vector preparation assessment
Product Overview :
This kit provides a rapid method for adenovirus titer determination, delivering results within 48 hours. The assay yields accurate quantification suitable for viral vector manufacturing and quality control.
Features & Benefits :
- Turnaround time of 48 hours accelerates process decision-making - Simplified workflow reduces manual handling compared to traditional TCID50 methods - Reproducible results support batch-to-batch consistency evaluation - Suitable for both crude lysates and purified vector preparations